China Money Network
Login
Join

Hongtai Capital Leads $14M Series A+ Round In Chinese Pharmaceutical Firm

  • July 31, 2019 — 11:33 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese pharmaceutical firm CGeneTech has raised over RMB100 million (US$14.52 million) in a series A+ round of financing led by Hongtai Capital, a venture capital... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: